Targeting ROS-Mediated Crosstalk Between Autophagy and Apoptosis in Cancer

Lixia Gao1, Jenni Loveless2, Chloe Shay3

  • 1International Academy of Targeted Therapeutics and Innovation, Chongqing University of Arts and Sciences, Chongqing, P. R. China.

Insights

Controlling the interplay between autophagy and apoptosis in cancer cells, particularly through reactive oxygen species (ROS), is key to effective cancer treatment. Understanding ROS-mediated crosstalk is crucial for developing novel cancer therapies.

Area of Science:

  • Oncology
  • Cellular Biology
  • Biochemistry

Background:

  • Autophagy and apoptosis are critical cell death pathways in cancer.
  • Crosstalk between these pathways presents a challenge in cancer therapy.
  • Reactive oxygen species (ROS) play a regulatory role in this crosstalk.

Purpose of the Study:

  • To discuss the complex relationship between ROS levels, autophagy, and apoptosis in cancer.
  • To highlight the significance of controlling ROS-mediated crosstalk for cancer treatment efficacy.

Main Methods:

  • Literature review and synthesis of existing research on ROS, autophagy, and apoptosis in cancer.
  • Analysis of mechanisms underlying ROS-mediated crosstalk between cell death pathways.

Main Results:

  • ROS are central regulators of the balance between autophagy and apoptosis in tumor cells.
  • Dysregulation of ROS levels impacts cancer cell fate under various treatments.
  • The complexity of ROS-mediated crosstalk poses challenges but also therapeutic opportunities.

Conclusions:

  • Targeting the ROS-mediated crosstalk between autophagy and apoptosis is a promising strategy for overcoming therapeutic resistance in cancer.
  • Further research into these intricate mechanisms can lead to more efficacious cancer treatments.

Related Concept Videos

Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.5K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.5K
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
13.6K